Scientific Background

GRACE Laboratories, LLC, has developed magnetic particle ELISA technology that can rapidly assess traumatic brain injury (TBI) and its potential consequences, stroke and seizures.

This technology is based on decades of scientific study of the AMPA receptor and provides real-time evidence of brain damage in TBI and epilepsy.

Detecting AMPA receptor peptides and their antibodies can differentiate brain-related seizures from nonepileptic seizures and assist in follow-up after treatment.

GRACE Laboratories, LLC, blood tests are capable of predicting consequences of TBI such as stroke, migraine, and seizures.

Home

Scientific Background

Technology & Products

Business Development

Publications

Media

Education

About Us

Contact Us